Bioabsorbable Stents Market Analysis

  • Report ID: 3612
  • Published Date: Sep 19, 2024
  • Report Format: PDF, PPT

Bioabsorbable Stents Market Analysis

The bioabsorbable stents market is segmented by product type into bioresorbable polymer-based stents, and bioresorbable metallic stents. Out of these, the bioresorbable polymer-based stents segment is expected to generate the largest market revenue by the end of 2030, and also grow with the highest CAGR of 7.50% during the forecast period. By absorption rate, the market is segmented into slow, and fast absorption stents. Out of these, the slow-absorption stents segment registered the largest revenue in the year 2020. By application, the market is segmented into coronary and peripheral artery diseases. Out of these, the coronary artery diseases segment is expected to grow with the highest CAGR during the forecast period and also attain the largest revenue by the end of 2030. Moreover, by end-user, the bioabsorbable stents market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. Out of these, the hospitals segment generated the largest revenue of USD 127.4 Million in the year 2020, and is further expected to touch USD 265.2 Million by the end of 2030.

Our in-depth analysis of the global market includes the following segments:

           Product

  • Bioresorbable Metallic Stents
  • Bioresorbable Polymer-Based Stents

            Absorption Rate

  • Fast Absorption Stents
  • Slow Absorption Stents

 

 

            Application

  • Peripheral,
  • Coronary Artery Diseases
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3612
  • Published Date: Sep 19, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing prevalence of cardiovascular diseases (cvds) and the rising focus of the government of nations to facilitate advance healthcare infrastructure are some of the major factors anticipated to drive the market growth.

The market is anticipated to attain a CAGR of 7.67% over the forecast period, i.e., 2021 – 2030.

The lack of skilled professionals for using stents and the availability of low-cost alternatives are estimated to hamper the market growth.

The market in Europe region is anticipated to garner the largest revenue of USD 252.3 Million by the end of 2030 and display significant business opportunities for market growth.

The major players in the market are Abbott, Elixir Medical Corporation, BIOTRONIK SE & Co KG, Arterius Limited, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample